What the Numbers Don't Tell You As your physician, I have to point out what raw weight-loss percentages leave out: Both Medications Produce Clinically Meaningful Results A 13.7% weight loss with semaglutide is transformative for most patients
Patients should maintain adequate hydration, and those with pre-existing renal impairment should be monitored carefully
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Oral semaglutide may also cause specific side effects related to its daily dosing schedule, such as more frequent gastrointestinal discomfort
The test reveals predispositions in peptide genetic pathwaysnot exact medication response or guaranteed outcomes
GHK-Cu affects over 4,000 human genes according to research, with particularly strong influences on genes related to tissue remodeling, antioxidant protection, and cellular regeneration